Tharimmune Profit Margin

Tharimmune (THAR) currently reports a profit margin of -6559.27% as of June 2026. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Tharimmune's profit margin history and peer comparisons.

Tharimmune's profit margin of -6559.27% is lower than the Healthcare sector average of 19.13%. That is roughly 34385.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Tharimmune's current -6559.27% should be judged against Healthcare norms (sector average: 19.13%) and against THAR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -6559.27%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Tharimmune, and consider following THAR for alerts when major investors trade the stock.

Tharimmune is classified in the Healthcare sector. On profit margin, it currently shows -6559.27% versus a sector average near 19.13%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THAR with unrelated industries.